Cargando…

Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis

OBJECTIVES: IL-36 agonists are pro-inflammatory cytokines involved in the pathogenesis of psoriasis. However, their role in the pathogenesis of arthritis and treatment response to DMARDs in PsA remains uncertain. Therefore, we investigated the IL-36 axis in the synovium of early, treatment-naïve PsA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boutet, Marie-Astrid, Nerviani, Alessandra, Lliso-Ribera, Gloria, Lucchesi, Davide, Prediletto, Edoardo, Ghirardi, Giulia Maria, Goldmann, Katriona, Lewis, Myles, Pitzalis, Costantino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188345/ https://www.ncbi.nlm.nih.gov/pubmed/31504934 http://dx.doi.org/10.1093/rheumatology/kez358

Ejemplares similares

Circulating and Synovial Pentraxin-3 (PTX3) Expression Levels Correlate With Rheumatoid Arthritis Severity and Tissue Infiltration Independently of Conventional Treatments Response
por: Boutet, Marie-Astrid, et al.
Publicado: (2021)

IL-23 skin and joint profiling in psoriatic arthritis: novel perspectives in understanding clinical responses to IL-23 inhibitors
por: Nerviani, Alessandra, et al.
Publicado: (2021)

IL-36, IL-37, and IL-38 Cytokines in Skin and Joint Inflammation: A Comprehensive Review of Their Therapeutic Potential
por: Boutet, Marie-Astrid, et al.
Publicado: (2019)

Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
por: Boutet, Marie-Astrid, et al.
Publicado: (2018)

A Pauci-Immune Synovial Pathotype Predicts Inadequate Response to TNFα-Blockade in Rheumatoid Arthritis Patients
por: Nerviani, Alessandra, et al.
Publicado: (2020)

nestedcv: an R package for fast implementation of nested cross-validation with embedded feature selection designed for transcriptomics and high-dimensional data
por: Lewis, Myles J, et al.
Publicado: (2023)

Role of chemokines in ectopic lymphoid structures formation in autoimmunity and cancer
por: Nerviani, Alessandra, et al.
Publicado: (2018)

M3C: Monte Carlo reference-based consensus clustering
por: John, Christopher R., et al.
Publicado: (2020)

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
por: Rivellese, Felice, et al.
Publicado: (2022)

B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure
por: Rivellese, F., et al.
Publicado: (2020)

Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC)
por: Lliso-Ribera, Gloria, et al.
Publicado: (2019)

Ectopic Lymphoid Structures: Powerhouse of Autoimmunity
por: Corsiero, Elisa, et al.
Publicado: (2016)

Can Synovial Pathobiology Integrate with Current Clinical and Imaging Prediction Models to Achieve Personalized Health Care in Rheumatoid Arthritis?
por: Humby, Frances Claire, et al.
Publicado: (2017)

Network analysis of synovial RNA sequencing identifies gene-gene interactions predictive of response in rheumatoid arthritis
por: Sciacca, Elisabetta, et al.
Publicado: (2022)

Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus
por: Rivellese, Felice, et al.
Publicado: (2021)

Follicular dendritic cell differentiation is associated with distinct synovial pathotype signatures in rheumatoid arthritis
por: El Shikh, Mohey Eldin M., et al.
Publicado: (2022)

Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis
por: Bettiol, Alessandra, et al.
Publicado: (2023)

Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis
por: Jones, Gareth W., et al.
Publicado: (2015)

New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
por: Pagani, Sara, et al.
Publicado: (2020)

Investigation of genetically regulated gene expression and response to treatment in rheumatoid arthritis highlights an association between IL18RAP expression and treatment response
por: Cherlin, Svetlana, et al.
Publicado: (2020)

Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms
por: Cantatore, Francesco Paolo, et al.
Publicado: (2017)

Role of synovial fibroblast subsets across synovial pathotypes in rheumatoid arthritis: a deconvolution analysis
por: Micheroli, Raphael, et al.
Publicado: (2022)

DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis
por: Wang, Susan Siyu, et al.
Publicado: (2023)

Lactate Buildup at the Site of Chronic Inflammation Promotes Disease by Inducing CD4(+) T Cell Metabolic Rewiring
por: Pucino, Valentina, et al.
Publicado: (2019)

Generation of restriction endonucleases barcode map to trace SARS-CoV-2 origin and evolution
por: Colombo, Federico, et al.
Publicado: (2021)

Pathological Role of Interleukin-6 in Psoriatic Arthritis
por: Ogata, Atsushi, et al.
Publicado: (2012)

Editorial: Immunology of Psoriatic Disease
por: Reali, Eva, et al.
Publicado: (2019)

BBmix: a Bayesian beta-binomial mixture model for accurate genotyping from RNA-sequencing
por: Vigorito, Elena, et al.
Publicado: (2023)

Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis
por: Ogdie, Alexis, et al.
Publicado: (2023)

Quality of Life in Psoriatic Patients: A Study Using the Short Form-36
por: Darjani, Abbas, et al.
Publicado: (2014)

Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease
por: Iznardo, Helena, et al.
Publicado: (2021)

Opposing Effects of Interleukin-36γ and Interleukin-38 on Trained Immunity
por: Teufel, Lisa U., et al.
Publicado: (2023)

Interleukin-1 Receptors Are Differentially Expressed in Normal and Psoriatic T Cells
por: Bebes, Attila, et al.
Publicado: (2014)

Spectrum: fast density-aware spectral clustering for single and multi-omic data
por: John, Christopher R, et al.
Publicado: (2020)

Interleukin-36 in Infectious and Inflammatory Skin Diseases
por: Buhl, Anna-Lena, et al.
Publicado: (2019)

Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis
por: Ferrari, Mathieu, et al.
Publicado: (2021)

ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia
por: Rivellese, Felice, et al.
Publicado: (2020)

IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?
por: Chen, Feier, et al.
Publicado: (2020)

IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis
por: Bridgewood, Charlie, et al.
Publicado: (2018)

Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease—results of the Immune Metabolic Associations in Psoriatic Arthritis study
por: Ferguson, Lyn D, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h2d3d76sad9ifd63i9hao2qiae